HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fry, T. J. Articles by Mackall, C. L. Search for Related Content PubMed PubMed Citation Articles by Fry, T. J. Articles by Mackall, C. L.

The Many Faces of IL-7: From Lymphopoiesis to Peripheral T Cell Maintenance

Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

	Abstract

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
IL-7 is well known as a lymphopoietic cytokine, but recent studies have also identified a critical role for IL-7 in peripheral T cell homeostasis. IL-7 is well poised to serve as a homeostatic cytokine because it is produced by resting stromal cells, the IL-7R is present on most T cells, and IL-7 down-regulates its own receptor. These features allow IL-7 to signal large numbers of resting T cells and to be efficiently used when supplies are limiting. Consistent with this, in normal hosts, IL-7 is required for survival of naive T cell populations, and IL-7 contributes to homeostatic cycling of naive and memory cells. In addition, lymphopenic hosts accumulate increased levels of IL-7, and the supranormal levels are largely responsible for inducing homeostatic peripheral expansion in response to lymphopenia. Thus, IL-7 plays critical and nonredundant roles in both T cell lymphopoiesis and in maintaining and restoring peripheral T cell homeostasis.

	Introduction

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
Interleukin-7 was discovered in 1988 as a result of its growth-promoting effects on B cell progenitors in vitro (1). During the ensuing decade, much of IL-7 research focused on lymphopoiesis where it plays a critical role. More recently, however, a central role for IL-7 in peripheral T cell homeostasis has also emerged. This review will summarize current understanding of the role IL-7 plays in lymphocyte development and then discuss in more depth the emerging role that IL-7 is assuming as a modulator of peripheral T cell homeostasis. The human gene for IL-7 resides on chromosome 8q12–13 and shares 81% homology with murine coding regions. IL-7 is a member of the type I cytokine family and signals through a heterodimer comprised of the common cytokine signaling -chain (_c) ² and IL-7R. Neither of these signaling elements is unique to IL-7; _c is shared with IL-2, IL-4, IL-9, IL-15, and IL-21, and IL-7R is also used by thymic stromal lymphopoietin (TSLP). Because _c is expressed ubiquitously on lymphocytes, IL-7 responsiveness is controlled largely by the presence or absence of IL-7R. Unlike other members of the _c cytokine family but similar to TSLP, IL-7 is produced by nonhemopoietic stromal cells in multiple organs including thymus, lymphoid organs, skin, intestine, and liver, among others. Thus, whereas the targets of IL-7 are developing B and T lymphocytes and mature T cells, immune cells play little, if any, role in IL-7 production.

	IL-7 and T cell lymphopoiesis

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
The unique, nonredundant role for IL-7 in murine B and T cell development is most clearly demonstrated by the paucity of lymphocytes present in IL-7- and IL-7R-deficient mice and following IL-7 or IL-7R neutralization in vivo. The subsequent description of patients with T^–B⁺NK⁺ SCID resulting from an IL-7R chain mutation confirmed that IL-7 is essential for human T cell lymphopoiesis. However, because these patients had B cells expressing the mutant IL-7R, these results demonstrated that IL-7 is not absolutely required for B cell development in humans (2). Nonetheless, it is likely that, under normal circumstances, IL-7 signaling contributes substantially to the efficient generation of the human B cell repertoire (3).

The effects of IL-7 on T cell lymphopoiesis are multiple and distinct for different lineages at different stages of differentiation. In some cases, such as in TCR rearrangement, the effect of IL-7 is indispensable, because cells are completely absent from IL-7^–/– mice. At other steps in T cell development, IL-7 plays a primary role under normal circumstances, but the effects can be rescued by other elements when IL-7 is limiting. For example, TSLP can substitute, albeit suboptimally, for IL-7 in thymopoiesis, and likely serves as the basis for less T cell deficiency in IL-7^–/– compared with IL-7R^–/– mice (4).

During lymphocyte development, IL-7R is first expressed on the common lymphoid progenitor (CLP) in the bone marrow, a cell initially considered to be the requisite progenitor for both T and B cell lymphopoiesis (5). The observation that CLPs expressed IL-7R led to the initial assumption that IL-7 signaling was sustained throughout the early steps in lymphopoiesis; however, recent evidence has indicated that IL-7R^– subsets also represent important stages in B cell and T cell development. One example is the recent description of the earliest T lineage progenitors within the thymus, which do not express IL-7R, yet efficiently generate T cells (6, 7). Furthermore, although the IL-7R⁺ CLP preferentially gives rise to B cell progenitors (8, 9), sustained expression of IL-7R chain in lymphoid progenitors impairs B cell development (10). Finally, CD34⁺CD38^–CD7⁺ lymphoid progenitor identified in human cord blood also lacks IL-7R (11). Therefore, whereas some early lymphoid progenitors can be identified by IL-7R expression, this is not universal and strict regulation of IL-7R expression appears to be a common and important theme in lymphopoiesis.

Beyond the earliest T lineage progenitor stage of thymopoiesis, IL-7 is critical for the differentiation of double-negative (DN) thymocytes. IL-7 is a potent growth factor for DN thymocytes, likely serving as an amplification step in thymopoiesis. In addition, because T cell development in IL-7- or IL-7R-deficient mice can be partially rescued by a bcl-2 transgene or deletion of Bax, IL-7’s capacity to prevent cell death contributes substantially to effects on thymopoiesis (12, 13, 14). Recent data demonstrated that both survival and proliferative signals generated through IL-7R via PI3K in DN thymocytes are required primarily to overcome inhibitory signals rendered by phosphatase and tensin homologue deleted on chromosome 10, because mice deficient in this factor can efficiently generate T cells in the absence of IL-7 (15). In addition to survival and proliferative effects, IL-7 also plays a direct role in inducing -chain rearrangement by augmenting histone acetylation and locus accessibility (16) and also contributes to -chain rearrangement (17).

At the DN3 stage of T cell development, signals generated by a productively rearranged -chain and pT (pre-TCR) serve to maintain IL-7R expression, perhaps allowing responsiveness to limiting concentrations of IL-7 and successful transition to the DN4 stage (18). A similar mechanism for maintaining IL-7R expression has been proposed for pre-BCR signaling (19). However, sensitivity to IL-7 is lost at the intermediate single-positive stage, and forced IL-7R expression inhibits the transcription factors necessary for progression to the double-positive phase resulting in a blockade in T cell development (20). Munitic et al. (21) have demonstrated that the forced expression of IL-7R beyond the DN stage also results in diminished size of the DN pool, and have suggested that this may occur as a result of IL-7 consumption, which results in a reduced supply of IL-7 available for DN thymocytes. Thus, during early T cell development, IL-7 signals are critical for survival, proliferation, and gene rearrangement in thymocytes, but loss of IL-7R expression allows normal T cell development to proceed and, perhaps, maintains an adequate DN pool size. Regulation of IL-7R also plays an important role during the double-positive stage of development because IL-7R re-expression is important for CD8⁺ lineage commitment (22, 23), an effect that may be regulated, in part, by the transcriptional repressor, GFI1b (24). Furthermore, Van De Wiele et al. (25) have reported that, based on patterns of STAT-5 phosphorylation, the responsiveness of human thymocytes to IL-7 was at least partially regained in thymocytes involved in the positive selection process.

The voluminous evidence that IL-7 is an indispensable element in normal thymopoiesis raised the intriguing possibility that diminished IL-7 production could be responsible for age-associated thymic involution and/or that IL-7 therapy may enhance thymopoiesis in lymphopenic patients or in aging individuals. Whereas this was an attractive hypothesis pursued by many laboratories, studies thus far have not provided convincing evidence that age-associated thymic involution is due to diminished IL-7 production (26), and in general, increasing IL-7 availability has not increased thymic size or thymic throughput. Included in this body of work are a number of studies of IL-7 transgenic mice that show contrasting phenotypes in the thymus, ranging from unaffected to, perhaps surprisingly, decreased thymic cellularity. A recent report suggested that a dose effect was an important element in these distinctions with the highest levels of IL-7 inducing diminished thymic size (27). This observation is supported by the diminished thymic size of nonhuman primates treated with pharmacologic doses of IL-7 (28). Furthermore, treatment of aged mice with IL-7 did not reverse histologic evidence of thymic involution (29). One exception may involve irradiation-based preparative regimens for bone marrow transplantation, wherein some reports have demonstrated that IL-7 therapy may accelerate recovery of thymic function (30), perhaps because the IL-7-producing thymic epithelial cells appear to be particularly sensitive to the effects of radiation (31). Therefore, although IL-7 therapy may hold promise for clinical application as an immunorestorative (discussed below), current evidence does not support the notion that IL-7 therapy, per se, increases thymic size and thymic throughput, or is capable of preventing or reversing thymic involution.

	IL-7 and peripheral T cell homeostasis

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
Early reports identified IL-7’s capacity to costimulate for TCR activation in mature T cells, but because animals lacking IL-7 had negligible numbers of peripheral T cells, the central role for IL-7 in peripheral T cell homeostasis remained largely underappreciated. However, several studies in the last 5 years have established IL-7 as a critical modulator of peripheral T cell homeostasis, the effects of which are most pronounced during T cell lymphopenia. Although an exhaustive review of the literature describing alterations in T cell physiology during lymphopenia is beyond the scope of this article (reviewed in Ref. 32), several points relevant in the context of IL-7 will be discussed.

Due to some of the ambiguity associated with terminology in the current literature, clear definitions are necessary. Homeostatic peripheral expansion (HPE) can be defined as the dramatic mitotic expansion of mature T cells occurring in lymphopenic hosts. The fact that mature T cells expand in lymphopenic environments has been appreciated for over 20 years (33), but the mechanisms have only recently been elucidated. Some investigators have also used the term "HPE" to describe the slow cycling of naive cells and/or the ongoing cycling of memory cells that occurs throughout life. Although these phenomena may represent a continuum, the extent and rate of cell turnover in T cell-replete vs lymphopenic animals differ substantially. Therefore, we prefer to use the term "homeostatic cycling" to describe the turnover of naive or memory cells, which 1) occurs in lymphoreplete hosts, 2) does not clearly result in expansion of cell numbers, and 3) does not alter the naive vs memory phenotype or functional profile of the cycling population. In contrast, "HPE" will be used to describe expansion that 1) occurs in lymphopenic hosts, 2) results in dramatic expansion of cell numbers, and 3) for naive cells, results in a conversion to a memory phenotype. It is now evident that HPE, as it occurs in lymphopenic hosts, results in full conversion to a memory phenotype (34, 35), and that gene expression induced following HPE is similar to that induced by encounter with cognate Ag (36). Whether memory cells generated via HPE share all of the functional characteristics of memory cells generated in response to cognate Ag remains an unresolved question. Indeed, genes related to cytolytic function seem to be expressed to greater extent on cells encountering cognate Ag when compared with cells undergoing HPE (36). Nonetheless, distinguishing between homeostatic cycling as it occurs in lymphoreplete hosts and HPE that occurs in lymphopenic hosts is useful for illustrating the contribution of IL-7 in modulating peripheral T cell homeostasis.

	Homeostatic cycling and survival of naive cells/recent thymic emigrants (RTEs)

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
Following thymic export, RTEs are preferentially incorporated into the periphery regardless of the size of the existing pool (37). Once in the periphery, RTEs continue to undergo differentiation and cycling. Although fully mature thymocytes generally show low IL-7R expression, Boursalian et al. (38) reported increasing expression of IL-7R following thymic export, with preferential peripheral expansion of the IL-7R^highCD8⁺ subset. Similarly, human cord blood T cells show enhanced responsiveness to IL-7 compared with adult naive T cell populations, and neonatal T cells, which are largely comprised of RTEs, demonstrate a high turnover rate and heightened responsiveness to IL-7 (39, 40). Thus, cycling of RTEs, which contributes to efficient postthymic T cell differentiation and maintenance of a diverse T cell repertoire, is highly correlated with IL-7 responsiveness. Furthermore, when IL-7 is administered to normal nonhuman primates, the percentage of cycling cells in the blood increases dramatically (41), with the most profound changes in the naive subset (42). Thus, exogenous administration of IL-7 is sufficient to induce widespread cycling of naive T populations in primates and RTEs in cord blood. In addition, IL-7 may also contribute to trafficking of RTEs to lymphoid tissues (43). Although Ag is not absolutely required for IL-7-induced cycling of RTEs, it appears likely that TCR signaling via cross-reactive environmental and/or low-affinity self-Ags is involved in much of the naive cell cycling induced by IL-7. Indeed, when exogenous IL-7 is administered with a cellular vaccine, IL-7-mediated expansion of Ag-specific T cell populations is much greater than the expansion of non-Ag-specific populations, thus demonstrating the synergy of concomitant TCR and IL-7 signaling (44). The adjuvant effect of IL-7 is most dramatic on subdominant Ags, wherein coadministration of IL-7 can dramatically augment effector cell generation (44).

Once RTEs are integrated into the naive peripheral pool of a T cell-replete host, they enter a resting phase characterized by no or very slow proliferation. Such quiescent cells nonetheless require signals from the external milieu, because the absence of class II and class I, respectively, results in a slow decline in naive CD4⁺ and CD8⁺ T cells following transfer (32). The persistence of naive cells in vivo is also dependent on the availability of IL-7 (45, 46, 47). Thus, the combination of IL-7 and low-affinity interactions with peptide:MHC, probably within the lymphoid tissues, allows for the persistence of naive T cells in vivo. As will be discussed below, similar interactions appear to induce more widespread T cell cycling in lymphopenic hosts.

Activation of T cells results in down-regulation of IL-7R, but there is re-expression on the resting memory pool. Interestingly, Kaech et al. (48) demonstrated that expression of IL-7R on a small numbers of CD8⁺ effector cells identifies that subset which is destined to differentiate into true memory cells, and we have demonstrated that IL-7 therapy augments the size of the CD8⁺ memory pool generated following immunization (44). Other reports have demonstrated an important role for IL-7 in the generation of CD4⁺ memory cells as well (49, 50). In addition, the expression of lung Kruppel-like factor, proposed to be a "quiescence factor" critical in naive and resting memory cells, depends on IL-7 for re-expression following activation (51). In terms of maintaining the CD8⁺ memory pool, memory cells cycle at a substantial rate throughout life and do not require MHC engagement for this to occur. However, CD8⁺ memory cells do require either IL-15 or IL-7 signaling, because this subset cannot be maintained in IL-15^–/–IL-7^–/–-deficient mice (52, 53). Requirements for maintaining CD4⁺ memory cells is less clear, with some reports suggesting that IL-7 does not play a role, but Seddon et al. (54) have suggested that IL-7 and TCR signals each contribute but with redundancy such that each signal may be sufficient.

In summary, in hosts with normal T cell numbers, basal levels of IL-7 are required for thymopoiesis, contribute to postthymic lymphocyte development by facilitating cycling and differentiation of RTEs as they assimilate into the peripheral T cell pool, and provide important survival signals for the naive T cell pool. Furthermore, regulation of IL-7R expression may be critical for efficient generation of the CD4⁺ and CD8⁺ memory pool following an immune response, and basal levels of IL-7 are sufficient to maintain survival of the CD8⁺ memory pool and may contribute to survival of the CD4⁺ memory pool.

	HPE of naive cells

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
Adoptive transfer of naive T cells into lymphopenic animals results in dramatic expansion via the process defined above as HPE. A variety of studies have confirmed that TCR signaling is critical for HPE. Indeed, when cognate Ag is available to T cells in the setting of lymphopenia, the magnitude of expansion induced exceeds that found in T cell-replete hosts responding to the same Ag (35), and the magnitude of expansion in response to cognate Ag exceeds that recently described to occur in response toward Ags with lower affinities for the TCR (55, 56). Thus, T cell repertoires generated during the process of HPE tend to be oligoclonal and skewed toward dominant Ags (35), a feature currently being exploited in the context of immunotherapy.

In addition to the exaggerated response to cognate Ag, there is also a fundamental change in the nature of the Ags capable of inducing proliferative T cell responses during lymphopenia. Goldrath and Bevan (55) and Ernst et al. (57) definitively demonstrated that HPE involves the proliferation of T cells toward Ags with low affinity for the TCR and which therefore represent both self-Ags responsible for positive selection in the thymus and low-affinity cross-reactive environmental Ags (55, 57, 58). Subsequently, Schluns et al. (59) and Tan et al. (60) demonstrated that IL-7 is required for the proliferation of naive cells to low-affinity Ags during HPE, whereas IL-15, IL-4, and other cytokines tested were not required. Importantly, the features of HPE and the role for IL-7 appears largely consistent regardless of the method by which lymphopenia is induced, including HPE of CD4⁺ T cells in normal lymphopenic neonatal mice (61, 62, 63). Therefore, the contribution of IL-7 to HPE is not a trivial effect of irradiation or other exogenous environmental factors but rather reflects a central requirement for IL-7 in the induction of HPE.

Some confusion has been generated by studies demonstrating that HPE can also occur in the absence of IL-7. Although it is possible that other factors present during lymphopenia contribute to HPE, the discrepancies regarding the effect of IL-7 have most commonly involved a subset of cells that undergo very rapid proliferation despite IL-7 neutralization in lymphopenic hosts. Indeed, CFSE dilution studies by several groups have consistently demonstrated the requirement for IL-7 for the slower proliferation characteristic of response to low-affinity Ags. However, in many of these reports, IL-7 neutralization has had little effect on the most rapidly proliferating pool contributing to HPE (60, 62). We have interpreted this to mean that proliferative responses resulting from high-affinity interactions (e.g., cognate Ag driven) are those that are least dependent upon IL-7, whereas the contribution of low-affinity T cells to HPE critically depends upon IL-7.

	Modulating peripheral T cell homeostasis via IL-7: the dosage effect

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
In general, cytokine receptor signaling is modulated primarily at the level of receptor expression, and IL-7 is no exception in this regard. What is exceptional about IL-7R when compared with other cytokine receptors, is the high expression of IL-7R on naive CD4⁺ and CD8⁺ resting T cells, with slightly higher levels on neonatal CD4⁺ cells (RTEs). Whereas other _c cytokine receptors are up-regulated following T cell activation, expression of IL-7R is lost on effector cells, but then re-expressed on memory cells. Furthermore, whereas _c cytokines typically induce their respective receptor expression, IL-7 down-regulates expression of IL-7R on CD8⁺ T cells through activation of the transcriptional repressor, GFI1 (64). IL-7R down-regulation contributes to maintenance of the size of peripheral T cell pool, because IL-7R transgenic mice, which are unable to down-regulate the receptor, show diminished peripheral T cell numbers (64). Thus, IL-7R expression is tightly regulated on peripheral T cells in a manner resulting in efficient use of this limiting resource; most resting cells express IL-7R, which allows them to receive basal IL-7 signals for survival and proliferation; however, the cells down-regulate IL-7R following IL-7 signaling or activation.

As described above, a role for IL-7 has been demonstrated in both naive cell survival and homeostatic cycling, which occurs in T cell-replete hosts, as well as in HPE, which occurs in response to lymphopenia. These studies have generally evaluated each process in the presence vs absence of IL-7 either through Ab neutralization or by using mice genetically manipulated so that they either cannot produce or respond to IL-7. Despite the insights that these studies provide, they have not clarified why the combination of TCR signaling and IL-7 induces survival and at most, minimal cycling without phenotypic or functional changes of naive cells in T cell-replete hosts, whereas the same combination induces dramatic expansion of naive cells and conversion to a memory phenotype and functional profile in lymphopenic hosts. Whereas non-IL-7-related changes in lymphopenic hosts such as deletion of regulatory cells could contribute, we have postulated that a dosage effect of IL-7 (65), resulting from increasing availability of this cytokine as lymphopenia progresses, plays a critical role in distinguishing "homeostatic cycling" in lymphoreplete hosts from "HPE," which occurs in lymphopenic hosts. The dosage effect model of IL-7 holds that progressive lymphopenia leads to diminished IL-7 use with a resultant increased availability of IL-7, thus allowing proliferation to lower and lower affinity TCR interactions (Fig. 1). Indeed, in conditions of severe lymphopenia, IL-7 appears capable of inducing proliferation independent of TCR signals (66). Although this model supports direct effects of IL-7 on T cells as a central component modulating the outcome of interaction between T cells and low-affinity Ags, other factors such as the IL-7-induced modulation of APCs could also contribute. Indeed, TSLP, which shares the IL-7R chain has been shown to modulate CD4⁺ HPE via dendritic cell effects (67), and we have observed IL-7 signaling on APCs as a critical component of its effects in vivo (68).

View larger version (114K): [in this window] [in a new window]   FIGURE 1. A dose-response model for the role of IL-7 in T cell homeostasis. In normal healthy hosts (left side, white background), basal levels of IL-7 primarily mediate survival and low-level cycling of RTEs. With the exception of the loss of CD31+ expression on human RTEs that undergo cycling (74 ), the cycling that results from basal IL-7 levels does not alter the phenotype of the cycling populations. IL-7 may also contribute to the moderate cycling of memory populations that occurs throughout life and to the generation of memory cells in response to cognate Ag, but these effects are not absolutely IL-7 dependent in normal hosts. During lymphopenia (right side, yellow background), IL-7 accumulates, resulting in the multifaceted process termed HPE. Following encounter with cognate Ag, the size of the memory pool is augmented compared with that generated in normal hosts. For naive cells, interaction with low-affinity Ags is sufficient to induce mitotic expansion and a conversion to a memory phenotype. Memory cell cycling is also more pronounced in lymphopenic hosts. *, Although cells generated via HPE of naive cells in lymphopenic hosts bear a memory phenotype, some investigators have described them as memory-like (designated as purple/green stippled), and ongoing work seeks to determine whether they are equivalent to "true-memory" cells.

	Potential therapeutic applications for IL-7

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 
Clinical development of IL-7 is currently underway. The most obvious application for this cytokine is to enhance immune reconstitution during lymphopenia. As discussed above, whereas true increases in thymic throughput will likely play a minor role in the clinical effects of IL-7 therapy, it is predicted that IL-7 will increase cycling of RTEs, which could provide important benefits for patients with profound T cell depletion. This may be especially important in the setting of T cell-depleted allogeneic stem cell transplantation, where diminished immune reconstitution remains a primary roadblock to progress. In addition, the capacity for IL-7 to augment responses to weak or low-affinity Ags raises the possibility that IL-7 may be useful as a vaccine adjuvant, especially when weak Ags, such as tumor Ags, may be targeted. IL-7 is also predicted to enhance the effectiveness of adoptive immunotherapy through its capacity to augment memory cell cycling. In addition to beneficial immunostimulatory effects, elevated levels of IL-7 may also contribute to autoimmunity or to proliferation of neoplastic lymphoid cells. If so, then approaches to neutralize this agent and/or to prevent the increases induced during T cell depletion could provide a clinical benefit.

	Acknowledgments

 
We thank Alfred Singer and Scott Durum for their careful review of the manuscript and for helpful suggestions. This review has focused primarily on the most recent IL-7 literature. Due to space constraints, we apologize that we were unable to reference many earlier reports that contributed greatly to the current understanding of the biology of this cytokine.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Address correspondence and reprint requests to Dr. Terry J. Fry, Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1-3940, 10 Center Drive, Bethesda, MD 20892. E-mail address: fryt{at}mail.nih.gov

² Abbreviations used in this paper: _c, common -chain; TSLP, thymic stromal lymphopoietin; CLP, common lymphoid progenitor; DN, double negative; HPE, homeostatic peripheral expansion; RTE, recent thymic emigrant.

Received for publication February 3, 2005. Accepted for publication February 14, 2005.

	References

Top Abstract Introduction IL-7 and T cell... IL-7 and peripheral T... Homeostatic cycling and survival... HPE of naive cells Modulating peripheral T cell... Potential therapeutic... References

 

1. Namen, A. E., S. Lupton, K. Hjerrild, J. Wignall, D. Y. Mochizuki, A. Schmierer, B. Mosley, C. J. March, D. Urdal, S. Gillis. 1988. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333: 571-573.[Medline]
2. Puel, A., S. F. Ziegler, R. H. Buckley, W. J. Leonard. 1998. Defective IL-7R expression in T^–B⁺NK⁺ severe combined immunodeficiency. Nat. Genet. 20: 394-397.[Medline]
3. Monroe, J. G., D. Allman. 2004. Keeping track of pro-B cells: a new model for the effects of IL-7 during B cell development. Eur. J. Immunol. 34: 2642-2646.[Medline]
4. Al-Shami, A., R. Spolski, J. Kelly, T. Fry, P. L. Schwartzberg, A. Pandey, C. L. Mackall, W. J. Leonard. 2004. A role for thymic stromal lymphopoietin in CD4⁺ T cell development. J. Exp. Med. 200: 159-168.[Abstract/Free Full Text]
5. Kondo, M., I. L. Weissman, K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.[Medline]
6. Bhandoola, A., A. Sambandam, D. Allman, A. Meraz, B. Schwarz. 2003. Early T lineage progenitors: new insights, but old questions remain. J. Immunol. 171: 5653-5658.[Free Full Text]
7. Montecino-Rodriguez, E., K. Dorshkind. 2003. To T or not to T: reassessing the common lymphoid progenitor. Nat. Immunol. 4: 100-101.[Medline]
8. Allman, D., A. Sambandam, S. Kim, J. P. Miller, A. Pagan, D. Well, A. Meraz, A. Bhandoola. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4: 168-174.[Medline]
9. Porritt, H. E., L. L. Rumfelt, S. Tabrizifard, T. M. Schmitt, J. C. Zuniga-Pflucker, H. T. Petrie. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20: 735-745.[Medline]
10. Purohit, S. J., R. P. Stephan, H. G. Kim, B. R. Herrin, L. Gartland, C. A. Klug. 2003. Determination of lymphoid cell fate is dependent on the expression status of the IL-7 receptor. EMBO J. 22: 5511-5521.[Medline]
11. Hao, Q. L., J. Zhu, M. A. Price, K. J. Payne, L. W. Barsky, G. M. Crooks. 2001. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97: 3683-3690.[Abstract/Free Full Text]
12. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033-1041.[Medline]
13. Maraskovsky, E., L. A. O’Reilly, M. Teepe, L. M. Corcoran, J. J. Peschon, A. Strasser. 1997. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1^–/– mice. Cell 89: 1011-1019.[Medline]
14. Khaled, A. R., W. Q. Li, J. Huang, T. J. Fry, A. S. Khaled, C. L. Mackall, K. Muegge, H. A. Young, S. K. Durum. 2002. Bax deficiency partially corrects interleukin-7 receptor deficiency. Immunity 17: 561-573.[Medline]
15. Hagenbeek, T. J., M. Naspetti, F. Malergue, F. Garcon, J. A. Nunes, K. B. Cleutjens, J. Trapman, P. Krimpenfort, H. Spits. 2004. The loss of PTEN allows TCR lineage thymocytes to bypass IL-7 and pre-TCR-mediated signaling. J. Exp. Med. 200: 883-894.[Abstract/Free Full Text]
16. Schlissel, M. S., S. D. Durum, K. Muegge. 2000. The interleukin-7 receptor is required for T cell receptor locus accessibility to the V(D)J recombinase. J. Exp. Med. 191: 1045-1050.[Abstract/Free Full Text]
17. Muegge, K., M. P. Vila, S. K. Durum. 1993. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor gene. Science 261: 93-95.[Abstract/Free Full Text]
18. Trigueros, C., K. Hozumi, B. Silva-Santos, L. Bruno, A. C. Hayday, M. J. Owen, D. J. Pennington. 2003. Pre-TCR signaling regulates IL-7 receptor expression promoting thymocyte survival at the transition from the double-negative to double-positive stage. Eur. J. Immunol. 33: 1968-1977.[Medline]
19. Fleming, H. E., C. J. Paige. 2001. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15: 521-531.[Medline]
20. Yu, Q., B. Erman, J. H. Park, L. Feigenbaum, A. Singer. 2004. IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORt: impact on thymocyte development. J. Exp. Med. 200: 797-803.[Abstract/Free Full Text]
21. Munitic, I., J. A. Williams, Y. Yang, B. Dong, P. J. Lucas, N. El Kassar, R. E. Gress, J. D. Ashwell. 2004. Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis. Blood 104: 4165-4172.[Abstract/Free Full Text]
22. Brugnera, E., A. Bhandoola, R. Cibotti, Q. Yu, T. I. Guinter, Y. Yamashita, S. O. Sharrow, A. Singer. 2000. Coreceptor reversal in the thymus: signaled CD4⁺8⁺ thymocytes initially terminate CD8⁺ transcription even when differentiating into CD8⁺ T cells. Immunity 13: 59-71.[Medline]
23. Yu, Q., B. Erman, A. Bhandoola, S. O. Sharrow, A. Singer. 2003. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8⁺ T cells. J. Exp. Med. 197: 475-487.[Abstract/Free Full Text]
24. Doan, L. L., M. K. Kitay, Q. Yu, A. Singer, S. Herblot, T. Hoang, S. E. Bear, H. C. Morse, III, P. N. Tsichlis, H. L. Grimes. 2003. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor expression, and T cell lineage commitment. J. Immunol. 170: 2356-2366.[Abstract/Free Full Text]
25. Van De Wiele, C. J., J. H. Marino, B. W. Murray, S. S. Vo, M. E. Whetsell, T. K. Teague. 2004. Thymocytes between the -selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation. J. Immunol. 172: 4235-4244.[Abstract/Free Full Text]
26. Sempowski, G. D., L. P. Hale, J. S. Sundy, J. M. Massey, R. A. Koup, D. C. Douek, D. D. Patel, B. F. Haynes. 2000. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J. Immunol. 164: 2180-2187.[Abstract/Free Full Text]
27. El Kassar, N., P. J. Lucas, D. B. Klug, M. Zamisch, M. Merchant, C. V. Bare, B. Choudhury, S. O. Sharrow, E. Richie, C. L. Mackall, R. E. Gress. 2004. A dose effect of IL-7 on thymocyte development. Blood 104: 1419-1427.[Abstract/Free Full Text]
28. Storek, J., T. Gillespy, III, H. Lu, A. Joseph, M. A. Dawson, M. Gough, J. Morris, R. C. Hackman, P. A. Horn, G. E. Sale, et al 2003. Interleukin-7 improves CD4 T cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 101: 4209-4218.[Abstract/Free Full Text]
29. Mackall, C. L., R. E. Gress. 1997. Thymic aging and T cell regeneration. Immunol. Rev. 160: 91-102.[Medline]
30. Bolotin, E., M. Smogorzewska, S. Smith, M. Widmer, K. Weinberg. 1996. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88: 1887-1894.[Abstract/Free Full Text]
31. Chung, B., L. Barbara-Burnham, L. Barsky, K. Weinberg. 2001. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 98: 1601-1606.[Abstract/Free Full Text]
32. Jameson, S. C.. 2002. Maintaining the norm: T cell homeostasis. Nat. Rev. Immunol. 2: 547-556.[Medline]
33. Stutman, O.. 1986. Postthymic T cell development. Immunol. Rev. 91: 159-194.[Medline]
34. Ge, Q., H. Hu, H. N. Eisen, J. Chen. 2002. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc. Natl. Acad. Sci. USA 99: 2989-2994.[Abstract/Free Full Text]
35. Mackall, C. L., C. V. Bare, L. A. Granger, S. O. Sharrow, J. A. Titus, R. E. Gress. 1996. Thymic-independent T cell regeneration occurs via antigen driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156: 4609-4616.[Abstract]
36. Goldrath, A. W., C. J. Luckey, R. Park, C. Benoist, D. Mathis. 2004. The molecular program induced in T cells undergoing homeostatic proliferation. Proc. Natl. Acad. Sci. USA 101: 16885-16890.[Abstract/Free Full Text]
37. Berzins, S. P., A. P. Uldrich, J. S. Sutherland, J. Gill, J. F. Miller, D. I. Godfrey, R. L. Boyd. 2002. Thymic regeneration: teaching an old immune system new tricks. Trends Mol. Med. 8: 469-476.[Medline]
38. Boursalian, T. E., J. Golob, D. M. Soper, C. J. Cooper, P. J. Fink. 2004. Continued maturation of thymic emigrants in the periphery. Nat. Immunol. 5: 418-425.[Medline]
39. Hassan, J., D. J. Reen. 2001. Human recent thymic emigrants—identification, expansion, and survival characteristics. J. Immunol. 167: 1970-1976.[Abstract/Free Full Text]
40. Schonland, S. O., J. K. Zimmer, C. M. Lopez-Benitez, T. Widmann, K. D. Ramin, J. J. Goronzy, C. M. Weyand. 2003. Homeostatic control of T cell generation in neonates. Blood 102: 1428-1434.[Abstract/Free Full Text]
41. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al 2003. IL-7 therapy dramatically alters peripheral T cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101: 2294-2299.[Abstract/Free Full Text]
42. Moniuszko, M., T. Fry, W. P. Tsai, M. Morre, B. Assouline, P. Cortez, M. G. Lewis, S. Cairns, C. Mackall, G. Franchini. 2004. Recombinant interleukin-7 induces proliferation of naive macaque CD4⁺ and CD8⁺ T cells in vivo. J. Virol. 78: 9740-9749.[Abstract/Free Full Text]
43. Chu, Y. W., S. A. Memon, S. O. Sharrow, F. T. Hakim, M. Eckhaus, P. J. Lucas, R. E. Gress. 2004. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 104: 1110-1119.[Abstract/Free Full Text]
44. Melchionda, F. M., T. J. Fry, M. J. Milliron, M. A. McKirdy, Y. Tagaya, and C. L. Mackall. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8⁺ memory cell pool. J. Clin. Invest. In press..
45. Boise, L. H., A. J. Minn, C. H. June, T. Lindsten, C. B. Thompson. 1995. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc. Natl. Acad. Sci. USA 92: 5491-5495.[Abstract/Free Full Text]
46. Vella, A., T. K. Teague, J. Ihle, J. Kappler, P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat 6 is probably not required for the effect of IL-4. J. Exp. Med. 186: 325-330.[Abstract/Free Full Text]
47. Rathmell, J. C., E. A. Farkash, W. Gao, C. B. Thompson. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167: 6869-6876.[Abstract/Free Full Text]
48. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.[Medline]
49. Kondrack, R. M., J. Harbertson, J. T. Tan, M. E. McBreen, C. D. Surh, L. M. Bradley. 2003. Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198: 1797-1806.[Abstract/Free Full Text]
50. Li, J., G. Huston, S. L. Swain. 2003. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J. Exp. Med. 198: 1807-1815.[Abstract/Free Full Text]
51. Endrizzi, B. T., S. C. Jameson. 2003. Differential role for IL-7 in inducing lung Kruppel-like factor (Kruppel-like factor 2) expression by naive versus activated T cells. Int. Immunol. 15: 1341-1348.[Abstract/Free Full Text]
52. Kieper, W. C., J. T. Tan, B. Bondi-Boyd, L. Gapin, J. Sprent, R. Ceredig, C. D. Surh. 2002. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8⁺ T cells. J. Exp. Med. 195: 1533-1539.[Abstract/Free Full Text]
53. Tan, J. T., B. Ernst, W. C. Kieper, E. LeRoy, J. Sprent, C. D. Surh. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8⁺ cells but are not required for memory phenotype CD4⁺ cells. J. Exp. Med. 195: 1523-1532.[Abstract/Free Full Text]
54. Seddon, B., P. Tomlinson, R. Zamoyska. 2003. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4: 680-686.[Medline]
55. Goldrath, A. W., M. J. Bevan. 1999. Low-affinity ligands for the TCR drive proliferation of mature CD8⁺ T cells in lymphopenic hosts. Immunity 11: 183-190.[Medline]
56. Clarke, S. R., A. Y. Rudensky. 2000. Survival and homeostatic proliferation of naive peripheral CD4⁺ T cells in the absence of self peptide:MHC complexes. J. Immunol. 165: 2458-2464.[Abstract/Free Full Text]
57. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181.[Medline]
58. Viret, C., F. S. Wong, C. A. Janeway, Jr. 1999. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10: 559-568.[Medline]
59. Schluns, K. S., W. C. Kieper, S. C. Jameson, L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.[Medline]
60. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737.[Abstract/Free Full Text]
61. Le Campion, A., C. Bourgeois, F. Lambolez, B. Martin, S. Leaument, N. Dautigny, C. Tanchot, C. Penit, B. Lucas. 2002. Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes. Proc. Natl. Acad. Sci. USA 99: 4538-4543.[Abstract/Free Full Text]
62. Min, B., R. McHugh, G. D. Sempowski, C. Mackall, G. Foucras, W. E. Paul. 2003. Neonates support lymphopenia-induced proliferation. Immunity 18: 131-140.[Medline]
63. Schuler, T., G. J. Hammerling, B. Arnold. 2004. Cutting edge: IL-7-dependent homeostatic proliferation of CD8⁺ T cells in neonatal mice allows the generation of long-lived natural memory T cells. J. Immunol. 172: 15-19.[Abstract/Free Full Text]
64. Park, J. H., Q. Yu, B. Erman, J. S. Appelbaum, D. Montoya-Durango, H. L. Grimes, A. Singer. 2004. Suppression of IL-7R transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.[Medline]
65. Fry, T. J., C. L. Mackall. 2001. Interleukin-7: master regulator of peripheral T cell homeostasis?. Trends Immunol. 22: 564-571.[Medline]
66. Seddon, B., R. Zamoyska. 2002. TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J. Immunol. 169: 3752-3759.[Abstract/Free Full Text]
67. Watanabe, N., S. Hanabuchi, V. Soumelis, W. Yuan, S. Ho, R. de Waal Malefyt, Y. J. Liu. 2004. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4⁺ T cell homeostatic expansion. Nat. Immunol. 5: 426-434.[Medline]
68. Fry, T. J., B. L. Christensen, K. L. Komschlies, R. E. Gress, C. L. Mackall. 2001. Interleukin-7 restores immunity in athymic T cell-depleted hosts. Blood 97: 1525-1533.[Abstract/Free Full Text]
69. Fry, T. J., E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman, et al 2001. A potential role for interleukin-7 in T cell homeostasis. Blood 97: 2983-2990.[Abstract/Free Full Text]
70. Bolotin, E., G. Annett, R. Parkman, K. Weinberg. 1999. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant. 23: 783-788.[Medline]
71. Napolitano, L. A., R. M. Grant, S. G. Deeks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson, J. M. McCune. 2001. Increased production of IL-7 accompanies HIV-1-mediated T cell depletion: implications for T cell homeostasis. Nat. Med. 7: 73-79.[Medline]
72. Ruiz-Mateos, E., R. de la Rosa, J. M. Franco, M. Martinez-Moya, A. Rubio, N. Soriano, A. Sanchez-Quijano, E. Lissen, M. Leal. 2003. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy. AIDS 17: 947-954.[Medline]
73. Ponchel, F., R. J. Verburg, S. J. Bingham, A. K. Brown, J. Moore, A. Protheroe, K. Short, C. A. Lawson, A. W. Morgan, M. Quinn, et al 2005. Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Res. Ther. 7: R80-R92.[Medline]
74. Kimmig, S., G. K. Przybylski, C. A. Schmidt, K. Laurisch, B. Mowes, A. Radbruch, A. Thiel. 2002. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195: 789-794.[Abstract/Free Full Text]

This article has been cited by other articles:

				T. Rose, A. H. Pillet, V. Lavergne, B. Tamarit, P. Lenormand, J. C. Rousselle, A. Namane, and J. Theze Interleukin-7 Compartmentalizes Its Receptor Signaling Complex to Initiate CD4 T Lymphocyte Response J. Biol. Chem., May 14, 2010; 285(20): 14898 - 14908. [Abstract] [Full Text] [PDF]

				F. Haugen, F. Norheim, H. Lian, A. J. Wensaas, S. Dueland, O. Berg, A. Funderud, B. S. Skalhegg, T. Raastad, and C. A. Drevon IL-7 is expressed and secreted by human skeletal muscle cells Am J Physiol Cell Physiol, April 1, 2010; 298(4): C807 - C816. [Abstract] [Full Text] [PDF]

				S. R. Jacobs, R. D. Michalek, and J. C. Rathmell IL-7 Is Essential for Homeostatic Control of T Cell Metabolism In Vivo J. Immunol., April 1, 2010; 184(7): 3461 - 3469. [Abstract] [Full Text] [PDF]

				J. Unsinger, M. McGlynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe, J. T. Muenzer, J. S. McDonough, J. Tschoep, T. A. Ferguson, J. E. McDunn, et al. IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis J. Immunol., April 1, 2010; 184(7): 3768 - 3779. [Abstract] [Full Text] [PDF]

				Z.-C. Ding, B. R. Blazar, A. L. Mellor, D. H. Munn, and G. Zhou Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype Blood, March 25, 2010; 115(12): 2397 - 2406. [Abstract] [Full Text] [PDF]

				O. Juffroy, F. Bugault, O. Lambotte, I. Landires, J.-P. Viard, L. Niel, A. Fontanet, J.-F. Delfraissy, J. Theze, and L. A. Chakrabarti Dual Mechanism of Impairment of Interleukin-7 (IL-7) Responses in Human Immunodeficiency Virus Infection: Decreased IL-7 Binding and Abnormal Activation of the JAK/STAT5 Pathway J. Virol., January 1, 2010; 84(1): 96 - 108. [Abstract] [Full Text] [PDF]

				A. U. van Lent, W. Dontje, M. Nagasawa, R. Siamari, A. Q. Bakker, S. M. Pouw, K. A. Maijoor, K. Weijer, J. J. Cornelissen, B. Blom, et al. IL-7 Enhances Thymic Human T Cell Development in "Human Immune System" Rag2-/-IL-2R{gamma}c-/- Mice without Affecting Peripheral T Cell Homeostasis J. Immunol., December 15, 2009; 183(12): 7645 - 7655. [Abstract] [Full Text] [PDF]

				K. Hochweller, T. Miloud, J. Striegler, S. Naik, G. J. Hammerling, and N. Garbi Homeostasis of dendritic cells in lymphoid organs is controlled by regulation of their precursors via a feedback loop Blood, November 12, 2009; 114(20): 4411 - 4421. [Abstract] [Full Text] [PDF]

				Y. Cui, H. Zhang, J. Meadors, R. Poon, M. Guimond, and C. L. Mackall Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts Blood, October 29, 2009; 114(18): 3831 - 3840. [Abstract] [Full Text] [PDF]

				A. L Gruver, M. S Ventevogel, and G. D Sempowski Leptin receptor is expressed in thymus medulla and leptin protects against thymic remodeling during endotoxemia-induced thymus involution J. Endocrinol., October 1, 2009; 203(1): 75 - 85. [Abstract] [Full Text] [PDF]

				T. Rose, O. Lambotte, C. Pallier, J.-F. Delfraissy, and J.-H. Colle Identification and Biochemical Characterization of Human Plasma Soluble IL-7R: Lower Concentrations in HIV-1-Infected Patients J. Immunol., June 15, 2009; 182(12): 7389 - 7397. [Abstract] [Full Text] [PDF]

				A. Andersson, S.-C. Yang, M. Huang, L. Zhu, U. K. Kar, R. K. Batra, D. Elashoff, R. M. Strieter, S. M. Dubinett, and S. Sharma IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer J. Immunol., June 1, 2009; 182(11): 6951 - 6958. [Abstract] [Full Text] [PDF]

				R. I. Azevedo, M. V. D. Soares, J. T. Barata, R. Tendeiro, A. Serra-Caetano, R. M. M. Victorino, and A. E. Sousa IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner Blood, March 26, 2009; 113(13): 2999 - 3007. [Abstract] [Full Text] [PDF]

				X. Wang, X. Chang, V. Facchinetti, Y. Zhuang, and B. Su MEKK3 Is Essential for Lymphopenia-Induced T Cell Proliferation and Survival J. Immunol., March 15, 2009; 182(6): 3597 - 3608. [Abstract] [Full Text] [PDF]

				A. M. Crawley, T. Katz, K. Parato, and J. B. Angel IL-2 receptor {gamma} chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127- T cell division and susceptibility to apoptosis Int. Immunol., January 1, 2009; 21(1): 29 - 42. [Abstract] [Full Text] [PDF]

				M. Catalfamo, M. Di Mascio, Z. Hu, S. Srinivasula, V. Thaker, J. Adelsberger, A. Rupert, M. Baseler, Y. Tagaya, G. Roby, et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells PNAS, December 16, 2008; 105(50): 19851 - 19856. [Abstract] [Full Text] [PDF]

				Y. Rochman and W. J. Leonard The Role of Thymic Stromal Lymphopoietin in CD8+ T Cell Homeostasis J. Immunol., December 1, 2008; 181(11): 7699 - 7705. [Abstract] [Full Text] [PDF]

				J. Y. Wu, L. E. Purton, S. J. Rodda, M. Chen, L. S. Weinstein, A. P. McMahon, D. T. Scadden, and H. M. Kronenberg Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways PNAS, November 4, 2008; 105(44): 16976 - 16981. [Abstract] [Full Text] [PDF]

				F. Miyagawa, Y. Tagaya, B. S. Kim, H. J. Patel, K. Ishida, T. Ohteki, T. A. Waldmann, and S. I. Katz IL-15 Serves as a Costimulator in Determining the Activity of Autoreactive CD8 T Cells in an Experimental Mouse Model of Graft-versus-Host-Like Disease J. Immunol., July 15, 2008; 181(2): 1109 - 1119. [Abstract] [Full Text] [PDF]

				O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia J. Immunol., June 1, 2008; 180(11): 7265 - 7275. [Abstract] [Full Text] [PDF]

				R. M. Dunham, B. Cervasi, J. M. Brenchley, H. Albrecht, A. Weintrob, B. Sumpter, J. Engram, S. Gordon, N. R. Klatt, I. Frank, et al. CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection J. Immunol., April 15, 2008; 180(8): 5582 - 5592. [Abstract] [Full Text] [PDF]

				M. G. H. Hernandez, L. Shen, and K. L. Rock CD40 on APCs Is Needed for Optimal Programming, Maintenance, and Recall of CD8+ T Cell Memory Even in the Absence of CD4+ T Cell Help J. Immunol., April 1, 2008; 180(7): 4382 - 4390. [Abstract] [Full Text] [PDF]

				A. Lang, J. D. Brien, I. Messaoudi, and J. Nikolich-Zugich Age-Related Dysregulation of CD8+ T Cell Memory Specific for a Persistent Virus Is Independent of Viral Replication J. Immunol., April 1, 2008; 180(7): 4848 - 4857. [Abstract] [Full Text] [PDF]

				Y. Yang, J. An, and N.-p. Weng Telomerase Is Involved in IL-7-Mediated Differential Survival of Naive and Memory CD4+ T Cells J. Immunol., March 15, 2008; 180(6): 3775 - 3781. [Abstract] [Full Text] [PDF]

				J. S. Haring, X. Jing, J. Bollenbacher-Reilley, H.-H. Xue, W. J. Leonard, and J. T. Harty Constitutive Expression of IL-7 Receptor {alpha} Does Not Support Increased Expansion or Prevent Contraction of Antigen-Specific CD4 or CD8 T Cells following Listeria monocytogenes Infection J. Immunol., March 1, 2008; 180(5): 2855 - 2862. [Abstract] [Full Text] [PDF]

				C. T. Jensen, C. Boiers, S. Kharazi, A. Lubking, T. Ryden, M. Sigvardsson, E. Sitnicka, and S. E. W. Jacobsen Permissive roles of hematopoietin and cytokine tyrosine kinase receptors in early T-cell development Blood, February 15, 2008; 111(4): 2083 - 2090. [Abstract] [Full Text] [PDF]

				J. J. Bell, J. S. Ellis, F. B. Guloglu, D. M. Tartar, H.-H. Lee, R. D. Divekar, R. Jain, P. Yu, C. M. Hoeman, and H. Zaghouani Early Effector T Cells Producing Significant IFN-{gamma} Develop into Memory J. Immunol., January 1, 2008; 180(1): 179 - 187. [Abstract] [Full Text] [PDF]

				T. Tomita, T. Kanai, Y. Nemoto, T. Totsuka, R. Okamoto, K. Tsuchiya, N. Sakamoto, and M. Watanabe Systemic, but Not Intestinal, IL-7 Is Essential for the Persistence of Chronic Colitis J. Immunol., January 1, 2008; 180(1): 383 - 390. [Abstract] [Full Text] [PDF]

				L. Cicin-Sain, I. Messaoudi, B. Park, N. Currier, S. Planer, M. Fischer, S. Tackitt, D. Nikolich-Zugich, A. Legasse, M. K. Axthelm, et al. Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates PNAS, December 11, 2007; 104(50): 19960 - 19965. [Abstract] [Full Text] [PDF]

				H. W. Lim and C. H. Kim Loss of IL-7 Receptor {alpha} on CD4+ T Cells Defines Terminally Differentiated B Cell-Helping Effector T Cells in a B Cell-Rich Lymphoid Tissue J. Immunol., December 1, 2007; 179(11): 7448 - 7456. [Abstract] [Full Text] [PDF]

				H.-R. Kim, K.-A Hwang, and I. Kang Dual Roles of IL-15 in Maintaining IL-7R{alpha}lowCCR7 Memory CD8+ T Cells in Humans via Recovering the Phosphatidylinositol 3-Kinase/AKT Pathway J. Immunol., November 15, 2007; 179(10): 6734 - 6740. [Abstract] [Full Text] [PDF]

				J. A. Politch, L. Tucker, F. P. Bowman, and D. J. Anderson Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men Hum. Reprod., November 1, 2007; 22(11): 2928 - 2935. [Abstract] [Full Text] [PDF]

				C. M. Paulos, A. Kaiser, C. Wrzesinski, C. S. Hinrichs, L. Cassard, A. Boni, P. Muranski, L. Sanchez-Perez, D. C. Palmer, Z. Yu, et al. Toll-like Receptors in Tumor Immunotherapy Clin. Cancer Res., September 15, 2007; 13(18): 5280 - 5289. [Abstract] [Full Text] [PDF]

				K. Rezvani, A. S. M. Yong, B. N. Savani, S. Mielke, K. Keyvanfar, E. Gostick, D. A. Price, D. C. Douek, and A. J. Barrett Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia Blood, September 15, 2007; 110(6): 1924 - 1932. [Abstract] [Full Text] [PDF]

				K. K. Hoyer, K. Wolslegel, H. Dooms, and A. K. Abbas Targeting T Cell-Specific Costimulators and Growth Factors in a Model of Autoimmune Hemolytic Anemia J. Immunol., September 1, 2007; 179(5): 2844 - 2850. [Abstract] [Full Text] [PDF]

				A. E.C. Broers, M. Bruinsma, S. J. Posthumus-van Sluijs, E.-J. Wils, H. Spits, B. Lowenberg, E. Braakman, and J. J. Cornelissen IL-7 mediated protection against minor antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells Haematologica, August 1, 2007; 92(8): 1099 - 1106. [Abstract] [Full Text] [PDF]

				K. M. Gosling, L. E. Makaroff, A. Theodoratos, Y.-H. Kim, B. Whittle, L. Rui, H. Wu, N. A. Hong, G. C. Kennedy, J.-A. Fritz, et al. A mutation in a chromosome condensin II subunit, kleisin beta, specifically disrupts T cell development PNAS, July 24, 2007; 104(30): 12445 - 12450. [Abstract] [Full Text] [PDF]

				J. N. Kochenderfer, J. L. Simpson, C. D. Chien, and R. E. Gress Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT Blood, July 1, 2007; 110(1): 450 - 460. [Abstract] [Full Text] [PDF]

				H.-R. Kim, K.-A Hwang, K.-C. Kim, and I. Kang Down-Regulation of IL-7R{alpha} Expression in Human T Cells via DNA Methylation J. Immunol., May 1, 2007; 178(9): 5473 - 5479. [Abstract] [Full Text] [PDF]

				T. Totsuka, T. Kanai, Y. Nemoto, S. Makita, R. Okamoto, K. Tsuchiya, and M. Watanabe IL-7 Is Essential for the Development and the Persistence of Chronic Colitis J. Immunol., April 15, 2007; 178(8): 4737 - 4748. [Abstract] [Full Text] [PDF]

				C. Fluur, A. De Milito, T. J. Fry, N. Vivar, L. Eidsmo, A. Atlas, C. Federici, P. Matarrese, M. Logozzi, E. Rajnavolgyi, et al. Potential Role for IL-7 in Fas-Mediated T Cell Apoptosis During HIV Infection J. Immunol., April 15, 2007; 178(8): 5340 - 5350. [Abstract] [Full Text] [PDF]

				A. S. Albuquerque, C. S. Cortesao, R. B. Foxall, R. S. Soares, R. M. M. Victorino, and A. E. Sousa Rate of Increase in Circulating IL-7 and Loss of IL-7R{alpha} Expression Differ in HIV-1 and HIV-2 Infections: Two Lymphopenic Diseases with Similar Hyperimmune Activation but Distinct Outcomes J. Immunol., March 1, 2007; 178(5): 3252 - 3259. [Abstract] [Full Text] [PDF]

				A. Malaspina, S. Moir, D. G. Chaitt, C. A. Rehm, S. Kottilil, J. Falloon, and A. S. Fauci Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7 Blood, March 1, 2007; 109(5): 2086 - 2088. [Abstract] [Full Text] [PDF]

				L. Vassena, M. Proschan, A. S. Fauci, and P. Lusso Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals PNAS, February 13, 2007; 104(7): 2355 - 2360. [Abstract] [Full Text] [PDF]

				L. Sun, H. Zhang, X. Feng, Y. Hou, L. Lu, and L. Fan Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus Lupus, February 1, 2007; 16(2): 121 - 128. [Abstract] [PDF]

				J. Feng, H. Wang, and H. C. Morse III Functional Deficiency in IL-7 Caused by an N-Ethyl-N-nitrosourea-Induced Point Mutation Genetics, February 1, 2007; 175(2): 545 - 551. [Abstract] [Full Text] [PDF]

				L. Swainson, S. Kinet, C. Mongellaz, M. Sourisseau, T. Henriques, and N. Taylor IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway Blood, February 1, 2007; 109(3): 1034 - 1042. [Abstract] [Full Text] [PDF]

				Y.-i. Seki, J. Yang, M. Okamoto, S. Tanaka, R. Goitsuka, M. A. Farrar, and M. Kubo IL-7/STAT5 Cytokine Signaling Pathway Is Essential but Insufficient for Maintenance of Naive CD4 T Cell Survival in Peripheral Lymphoid Organs J. Immunol., January 1, 2007; 178(1): 262 - 270. [Abstract] [Full Text] [PDF]

				J. Ho, S. Moir, A. Malaspina, M. L. Howell, W. Wang, A. C. DiPoto, M. A. O'Shea, G. A. Roby, R. Kwan, J. M. Mican, et al. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms PNAS, December 19, 2006; 103(51): 19436 - 19441. [Abstract] [Full Text] [PDF]

				N. Bosco, F. Agenes, A. G. Rolink, and R. Ceredig Peripheral T Cell Lymphopenia and Concomitant Enrichment in Naturally Arising Regulatory T Cells: The Case of the Pre-T{alpha} Gene-Deleted Mouse J. Immunol., October 15, 2006; 177(8): 5014 - 5023. [Abstract] [Full Text] [PDF]

				K. D. Klonowski, K. J. Williams, A. L. Marzo, and L. Lefrancois Cutting Edge: IL-7-Independent Regulation of IL-7 Receptor {alpha} Expression and Memory CD8 T Cell Development J. Immunol., October 1, 2006; 177(7): 4247 - 4251. [Abstract] [Full Text] [PDF]

				C. Bourgeois and B. Stockinger CD25+CD4+ Regulatory T Cells and Memory T Cells Prevent Lymphopenia-Induced Proliferation of Naive T Cells in Transient States of Lymphopenia J. Immunol., October 1, 2006; 177(7): 4558 - 4566. [Abstract] [Full Text] [PDF]

				E. N. Kersh Impaired Memory CD8 T Cell Development in the Absence of Methyl-CpG-Binding Domain Protein 2 J. Immunol., September 15, 2006; 177(6): 3821 - 3826. [Abstract] [Full Text] [PDF]

				K. Fukatsu, T. Moriya, F. Ikezawa, Y. Maeshima, J. Omata, Y. Yaguchi, K. Okamoto, H. Mochizuki, H. Hiraide, and G. Hardy Interleukin-7 Dose-Dependently Restores Parenteral Nutrition-Induced Gut-Associated Lymphoid Tissue Cell Loss but Does Not Improve Intestinal Immunoglobulin A Levels JPEN J Parenter Enteral Nutr, September 1, 2006; 30(5): 388 - 394. [Abstract] [Full Text] [PDF]

				B. Martin, C. Becourt, B. Bienvenu, and B. Lucas Self-recognition is crucial for maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environment Blood, July 1, 2006; 108(1): 270 - 277. [Abstract] [Full Text] [PDF]

				P. J. Staton, A. B. Carpenter, and S. H. Jackman IL-7 Is a Critical Factor in Modulating Lesion Development in Skn-Directed Autoimmunity J. Immunol., April 1, 2006; 176(7): 3978 - 3986. [Abstract] [Full Text] [PDF]

				S. Ramanathan, J. Gagnon, C. Leblanc, R. Rottapel, and S. Ilangumaran Suppressor of Cytokine Signaling 1 Stringently Regulates Distinct Functions of IL-7 and IL-15 In Vivo during T Lymphocyte Development and Homeostasis J. Immunol., April 1, 2006; 176(7): 4029 - 4041. [Abstract] [Full Text] [PDF]

				H.-R. Kim, M. S. Hong, J. M. Dan, and I. Kang Altered IL-7R{alpha} expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses Blood, April 1, 2006; 107(7): 2855 - 2862. [Abstract] [Full Text] [PDF]

				A. Malaspina, S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T.-W. Chun, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7 PNAS, February 14, 2006; 103(7): 2262 - 2267. [Abstract] [Full Text] [PDF]

				K. H. Ely, T. Cookenham, A. D. Roberts, and D. L. Woodland Memory T Cell Populations in the Lung Airways Are Maintained by Continual Recruitment J. Immunol., January 1, 2006; 176(1): 537 - 543. [Abstract] [Full Text] [PDF]

				A. Chandele and S. M. Kaech Cutting Edge: Memory CD8 T Cell Maturation Occurs Independently of CD8{alpha}{alpha} J. Immunol., November 1, 2005; 175(9): 5619 - 5623. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fry, T. J. Articles by Mackall, C. L. Search for Related Content PubMed PubMed Citation Articles by Fry, T. J. Articles by Mackall, C. L.